Urologic Oncology: Seminars and Original Investigations
Publisher: Elsevier · ISSN 1078-1439 · 68 articles
- Prognostic utility of preoperative NLR, PLR, SII in penile cancer: A National Cohort Study
- The added value of systematic biopsy in the MRI-targeted prostate biopsy era: Correlation with radical prostatectomy findings
- Re: Development and validation of a computational histology artificial intelligence-powered prognostic biomarker in muscle-invasive bladder cancer
- Impact of obesity with metabolic comorbidities on oncologic outcomes in patients with upper tract urothelial carcinoma
- Editorial commentary
- Optimizing testicular cancer therapy: Survivorship perspectives on reducing late toxicities without compromising outcomes
- Unmet needs in penile cancer: Review and perspectives from the Global Society of Rare Genitourinary Tumors
- Urethral cancer management in contemporary practice: A review
- Featured SUO Fellow: Steven Monda, MD, MSCI
- Calendar-time bias in a TriNetX study of GLP-1 receptor agonists, SGLT2 inhibitors and bladder cancer survival
- Is all gross hematuria high risk? Age-stratified outcomes after anticoagulation initiation using a large claims database
- FOXD1 upregulates DARS2-mediated glycolysis to drive cisplatin resistance in bladder cancer
- Intraoperative indocyanine green fluorescence guidance to reduce ureteroenteric anastomotic strictures during robot-assisted radical cystectomy. A systematic review and meta-analysis
- CDKL1 facilitates tumorigenesis and metastasis of bladder urothelial carcinoma by activating SIRT1/Wnt/β-catenin signaling
- Performance of the EORTC and CUETO risk prediction models in contemporary patients undergoing transurethral resection of bladder tumor with blue light cystoscopy
- Advancing clinical trials for rare renal cell carcinoma subtypes: Consensus statements from the International Kidney Cancer Symposium North America 2025 think tank
- Perioperative and survival outcomes of synchronous vs. metachronous upper tract urothelial carcinoma among bladder cancer patients treated with radical cystectomy and nephroureterectomy: Results from an International Multicenter Collaborative Study—On behalf of the Young Academic Urology (YAU) Urothelial Working Group
- Development and internal validation of machine-learning models to predict adverse pathological features in upper tract urothelial carcinoma
- Clinical characteristics and oncological outcomes of upper tract urothelial carcinoma in patients with personal or family history of Lynch-syndrome-associated cancers
- Cryoablation for localized prostate cancer: Feasibility in large prostates
- Incidental bladder cancer detected by routine cystoscopy before robot-assisted radical prostatectomy: A multicenter retrospective study
- Epidemiological trends in penile cancer and the evolving role of dynamic sentinel lymph node biopsy
- The role of lymph node dissection in upper tract urothelial carcinoma
- Benign but burdensome: Complications and management of benign prostatic hyperplasia during active surveillance of prostate cancer in a large cohort
- Predicting long-term metastatic risk after radical prostatectomy: Adding Genomic Prostate Score, grade group, and cribriform size to unfavorable histology burden translates into minimal incremental discrimination
- Quantitative core-level tumor burden and grading in MRI-targeted vs. systematic prostate biopsy: A within-patient paired analysis
- Intraductal carcinoma of the prostate does not independently predict adverse outcomes after radical prostatectomy: A National Cancer Database analysis
- Comparison and interpretability of machine learning algorithms to predict survival of patients with prostate cancer
- Prostate lymphoma uncovered during urological encounters: Diagnostic challenges and clinical outcomes in a case series with systematic review of the literature
- FOCS-24: An integrated oncologic–functional endpoint and its preoperative nomogram after focal therapy for localized prostate cancer